Cargando…

Molecular Targeted Therapy in the Treatment of Chordoma: A Systematic Review

Objectives: Chordoma is a rare bone malignancy that affects the spine and skull base. Treatment dilemma leads to a high rate of local relapse and distant metastases. Molecular targeted therapy (MTT) is an option for advanced chordoma, but its therapeutic efficacy and safety have not been investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Tong, Jin, Jiali, Jiang, Cong, Huang, Runzhi, Yin, Huabin, Song, Dianwen, Cheng, Liming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367227/ https://www.ncbi.nlm.nih.gov/pubmed/30775316 http://dx.doi.org/10.3389/fonc.2019.00030

Ejemplares similares

Research hotspots and trends of chordoma: A bibliometric analysis
por: Gao, Jianxuan, et al.
Publicado: (2022)

The Roles of Magnetic Resonance-Guided Focused Ultrasound in Pain Relief in Patients With Bone Metastases: A Systemic Review and Meta-Analysis
por: Han, Xiaying, et al.
Publicado: (2021)

The Clinical Characteristics and Prediction Nomograms for Primary Spine Malignancies
por: Zhou, Lei, et al.
Publicado: (2021)

The Integrated Transcriptome Bioinformatics Analysis Identifies Key Genes and Cellular Components for Spinal Cord Injury-Related Neuropathic Pain
por: Huang, Runzhi, et al.
Publicado: (2020)

B7-H3 as a Target for CAR-T Cell Therapy in Skull Base Chordoma
por: Long, Cheng, et al.
Publicado: (2021)

The role of toll-like receptors (TLRs) in pan-cancer
por: Huang, Runzhi, et al.
Publicado: (2022)

Emerging target discovery and drug repurposing opportunities in chordoma
por: Freed, Daniel M., et al.
Publicado: (2022)

Prognostic molecular biomarkers in chordomas: A systematic review and identification of clinically usable biomarker panels
por: Rubino, Franco, et al.
Publicado: (2022)

Pure proton therapy for skull base chordomas and chondrosarcomas: A systematic review of clinical experience
por: Nie, Menglin, et al.
Publicado: (2022)

Editorial: Chordoma: advances in biology and clinical management
por: Gardner, Paul, et al.
Publicado: (2023)

Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis
por: Huang, Runzhi, et al.
Publicado: (2021)

Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
por: Meng, Tong, et al.
Publicado: (2019)

The construction and analysis of tumor-infiltrating immune cell and ceRNA networks in recurrent soft tissue sarcoma
por: Huang, Runzhi, et al.
Publicado: (2019)

Clinicopathological and Prognostic Characteristics in Dedifferentiated/Poorly Differentiated Chordomas: A Pooled Analysis of Individual Patient Data From 58 Studies and Comparison With Conventional Chordomas
por: Liu, Fu-Sheng, et al.
Publicado: (2021)

Dramatic Response of a Large Sacral Chordoma to Intensity Modulated Proton Beam Therapy
por: Schneider, Craig, et al.
Publicado: (2017)

SMARCB1/INI1 loss in skull base conventional chordomas: a clinicopathological and molecular analysis
por: Righi, Alberto, et al.
Publicado: (2023)

RONC-32. LOCAL CONTROL FOLLOWING PROTON THERAPY FOR PEDIATRIC CHORDOMA
por: Indelicato, Daniel, et al.
Publicado: (2020)

A correlation analysis of sacrococcygeal chordoma imaging and clinical characteristics with the prognostic factors
por: Zhao, Fei, et al.
Publicado: (2022)

Novel targeted therapies in chordoma: an update
por: Di Maio, Salvatore, et al.
Publicado: (2015)

The Surgical Approach Combined With Minimally Invasive Surgery for Sacral Chordoma
por: Garcia Mora, Mauricio, et al.
Publicado: (2021)

Circulating tumor DNA – A potential aid in the management of chordomas
por: Frederico, Stephen C., et al.
Publicado: (2022)

Methylation-based reclassification and risk stratification of skull-base chordomas
por: Huo, Xulei, et al.
Publicado: (2022)

The role of Gamma Knife radiosurgery in the management of skull base chordoma
por: Wang, Kuanyu, et al.
Publicado: (2023)

Spine extra-osseous chordoma mimicking neurogenic tumors: report of three cases and review of the literatures
por: Yang, Jian, et al.
Publicado: (2016)

Proteomics and phosphoproteomics of chordoma biopsies reveal alterations in multiple pathways and aberrant kinases activities
por: Hang, Jing, et al.
Publicado: (2022)

Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
por: Huang, Wei, et al.
Publicado: (2020)

Molecular profiling of chordoma
por: SCHEIL-BERTRAM, STEFANIE, et al.
Publicado: (2014)

Collagen Type III Alpha 1 chain regulated by GATA‐Binding Protein 6 affects Type II IFN response and propanoate metabolism in the recurrence of lower grade glioma
por: Huang, Runzhi, et al.
Publicado: (2020)

Proton Therapy for Skull-Base Chordomas and Chondrosarcomas: Initial Results From the Beaumont Proton Therapy Center
por: Parzen, Jacob S, et al.
Publicado: (2021)

SPC24 is critical for anaplastic thyroid cancer progression
por: Yin, Huabin, et al.
Publicado: (2017)

Low expression of H3K27me3 is associated with poor prognosis in conventional chordoma
por: Wei, Jie, et al.
Publicado: (2022)

Durable Response of Spinal Chordoma to Combined Inhibition of IGF-1R and EGFR
por: Aleksic, Tamara, et al.
Publicado: (2016)

Incidence, Treatment, and Survival Patterns for Sacral Chordoma in the United States, 1974–2011
por: Yu, Esther, et al.
Publicado: (2016)

Response of Metastatic Chordoma to the Immune Checkpoint Inhibitor Pembrolizumab: A Case Report
por: Wu, Xiaoli, et al.
Publicado: (2020)

Intraoperative Magnetic Resonance Imaging Assisted Endoscopic Endonasal Resection of Clival Chordomas
por: Gulsuna, Beste, et al.
Publicado: (2022)

PALB2 as a factor to predict the prognosis of patients with skull base chordoma
por: Xiong, Yujia, et al.
Publicado: (2022)

High systemic inflammation score is associated with adverse survival in skull base chordoma
por: Li, Mingxuan, et al.
Publicado: (2022)

Clinical Implication of Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Skull Base Chordoma Patients
por: Li, Mingxuan, et al.
Publicado: (2021)

A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma
por: Zhao, Chenglong, et al.
Publicado: (2022)

The Construction and Comprehensive Analysis of ceRNA Networks and Tumor-Infiltrating Immune Cells in Bone Metastatic Melanoma
por: Huang, Runzhi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_142ttu60ansvl590rgb47jpnvu